KAITLYN CARIAGA: Open Payments
NPI 1114634136 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$492 in 21 payments from 8 companies in 2025. Trend: 2023 $125 · 2024 $60 · 2025 $492
Food & beverage: $492
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $107 |
| Mallinckrodt Hospital Products Inc. | 4 | $99 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $73 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $68 |
| GlaxoSmithKline, LLC. | 3 | $64 |
| Amgen Inc. | 1 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| Novo Nordisk Inc | 1 | $25 |
Products named: JYNARQUE, TERLIVAZ, Kerendia, JARDIANCE, BENLYSTA, KRYSTEXXA, Fabhalta, Ozempic.
Industry payments across FL — which companies pay providers there.
